Breast cancer screening in BRCA1 and BRCA2 mutation carriers after risk reducing salpingo-oophorectomy

By Fakkert Ingrid   Jansen Liesbeth   Meijer Kees   Kok Theo   Oosterwijk Jan   Mourits Marian   Bock Geertruida  

Breast Cancer Research and Treatment, Vol. 129, Iss. 1, 2011-08 ,pp. : 157-164

Springer Publishing Company

Access to resources Recommend Favorite

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2

By Neibergs Holly  

The Women's Oncology Review, Vol. 4, Iss. 1, 2004-01 ,pp. : 59-60

Informa Healthcare

Access to resources Recommend Favorite

Relative contributions of BRCA1 and BRCA2 mutations to “triple-negative” breast cancer in Ashkenazi Women

By Comen E.   Davids M.   Kirchhoff T.   Hudis C.   Offit K.   Robson M.  

Breast Cancer Research and Treatment, Vol. 129, Iss. 1, 2011-08 ,pp. : 185-190

Springer Publishing Company

Access to resources Recommend Favorite

The Leu33Pro polymorphism in the ITGB3 gene does not modify BRCA1/2-associated breast or ovarian cancer risks: results from a multicenter study among 15,542 BRCA1 and BRCA2 mutation carriers

By Jakubowska Anna   Rozkrut Dominik   Antoniou Antonis   Hamann Ute   Lubinski Jan  

Breast Cancer Research and Treatment, Vol. 121, Iss. 3, 2010-06 ,pp. : 639-649

Springer Publishing Company

Access to resources Recommend Favorite

Recurrent mutation testing of BRCA1 and BRCA2 in Asian breast cancer patients identify carriers in those with presumed low risk by family history

By Kang Peter   Phuah Sze   Sivanandan Kavitta   Kang In   Thirthagiri Eswary   Liu Jian   Hassan Norhashimah   Yoon Sook-Yee   Thong Meow   Hui Miao   Hartman Mikael   Yip Cheng   Mohd Taib Nur   Teo Soo  

Breast Cancer Research and Treatment, Vol. 144, Iss. 3, 2014-04 ,pp. : 635-642

Springer Publishing Company

Access to resources Recommend Favorite